title: [The organization of the mitotic apparatus poles in etoposide-treated CHO-K1 cells].
abstract: In this study, we have examined the organization of the mitotic spindle poles in CHO-K1 cells dividing after treatment with the etoposide (1 h, 25 microM). We studied at various periods after the treatment: 1) the distribution of gamma-tubulin in mitotic cells by immunofluorescent staining; 2) the level of posttranslational modification of a-tubulin in the spindle microtubules by immunoelectron microscopy; 3) the ultrastructure of the mitotic apparatus poles by standard electron microscopy. In 48 h after the addition of the agent we identified considerable changes in the ultrastructure of poles in etoposide-treated CHO-K1 cells with bipolar and multipolar spindles. The number of centrioles increased. The centrioles were unevenly distributed among the poles, and some centrioles were not explicitly involved in the organization of mitotic spindle, furthermore they can differ in the number of outgrowing microtubules. Most centrioles were without fibrillar halo. In 48 h after the addition of etoposide, electron microscopy of cells after immunoperoxidase staining with antibodies to acetylated and tyrosinated alpha-tubulin has shown that different poles of a multipolar spindle within the same cell are stained differently for tyr-tubulin but not for acet-tubulin. Immunofluorescence staining for gamma-tubulin also points to different organization of poles in the same spindle. Our findings provide the first evidence that the pattern of immunostaning and the ultrastructure of mitotic apparatus poles differ in the cells dividing at various periods after etoposide treatment.
authors.forename: E E
authors.initials: EE
authors.lastname: Balashova
authors.forename: S S
authors.initials: SS
authors.lastname: Riaskina
authors.forename: T M
authors.initials: TM
authors.lastname: Vinogradova
authors.forename: V B
authors.initials: VB
authors.lastname: Bystrevskaia
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D016466:CHO Cells; D002502:Centrioles / Q000378:metabolism; D006224:Cricetinae; D003412:Cricetulus; D005047:Etoposide / Q000494:pharmacology*; D008856:Microscopy, Fluorescence; D016253:Microscopy, Immunoelectron; D008870:Microtubules / Q000378:metabolism / Q000648:ultrastructure; D008938:Mitosis / Q000187:drug effects; D008941:Spindle Apparatus / Q000187:drug effects* / Q000378:metabolism* / Q000648:ultrastructure; D013997:Time Factors; D014404:Tubulin / Q000378:metabolism / Q000648:ultrastructure
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014404:Tubulin; D005047:Etoposide